3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Neoplasm Metastasis
36
Leukemia, Myeloid, Acute
32
Multiple Myeloma
27
Lymphoma
23
Breast Neoplasms
18
Prostatic Neoplasms
17
Pancreatic Neoplasms
17
Colorectal Neoplasms
17
Lymphoma, Large B-Cell, Diffuse
15
Burkitt Lymphoma
15
Myelodysplastic Syndromes
14
Leukemia, Lymphocytic, Chronic, B-Cell
14
Triple Negative Breast Neoplasms
12
Ovarian Neoplasms
12
Precursor Cell Lymphoblastic Leukemia-Lymphoma
11
Melanoma
11
Lung Neoplasms
11
Sarcoma
10
Lymphoma, T-Cell
9
Glioma
9
Carcinoma, Non-Small-Cell Lung
9
Neuroblastoma
8
Neoplasms
8
Fallopian Tube Neoplasms
8
Carcinoma, Renal Cell
8
Squamous Cell Carcinoma of Head and Neck
7
Lymphoma, Non-Hodgkin
7
Lymphoma, Follicular
7
Leukemia, Biphenotypic, Acute
7
Endometrial Neoplasms
7
Interventions
tislelizumab
3
toripalimab
1
tazemetostat
1
sintilimab
1
pembrolizumab
1
osimertinib
1
enzalutamide
1
envafolimab
1
WW Domain-Containing Oxidoreductase
1
Ultrasonography, Doppler
1
Ultrasonography
1
Specimen Handling
1
Radiotherapy
1
Oxaliplatin
1
Off-Label Use
1
Leucovorin
1
Injections
1
Indocyanine Green
1
Immune Checkpoint Inhibitors
1
Histocompatibility Testing
1
Fluorouracil
1
Fluorodeoxyglucose F18
1
Carboplatin
1
Blood Specimen Collection
1
Bevacizumab
1
130-nm albumin-bound paclitaxel
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Solid Tumor
×
Biopsy
×
90 days
×
Clear all
No trials found.